Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello D Bronstein

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 23, 2022
Survivin: A Potential Marker of Resistance to Somatostatin Receptor LigandsClarissa G Borba Herkenhoff, Ericka B Trarbach, Rafael Loch Batista, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|May 18, 2011
[Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil]Leonardo Vieira Neto, Julio Abucham, Luiz Antônio de Araujo, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|January 11, 2012
[Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil]Leonardo Vieira Neto, Julio Abucham, Luiz Antônio de Araujo, et al.
Neuroendocrinology|May 11, 2016
Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable EventAlessandra Casagrande, Marcello D Bronstein, Raquel S Jallad, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Growth hormone should be used only for approved indicationsDavid R Clemmons, Mark Molitch, Andrew R Hoffman, et al.
Clinical Endocrinology|August 5, 2006
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomasFelipe F Casanueva, Mark E Molitch, Janet A Schlechte, et al.
Pituitary|January 29, 2010
Management of prolactinomas in Brazil: an electronic surveyLucio Vilar, Luciana Ansaneli Naves, Luiz Augusto Casulari, et al.
The Journal of Clinical Endocrinology and Metabolism|February 10, 2015
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trialShlomo Melmed, Vera Popovic, Martin Bidlingmaier, et al.
Pituitary|June 10, 2016
Challenges in the diagnosis and management of acromegaly: a focus on comorbiditiesAlin Abreu, Alejandro Pinzón Tovar, Rafael Castellanos, et al.
Endocrine-Related Cancer|February 18, 2014
p27 variant and corticotropinoma susceptibility: a genetic and in vitro studyTomoko Sekiya, Marcello D Bronstein, Katiuscia Benfini, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|October 23, 2022
Survivin: A Potential Marker of Resistance to Somatostatin Receptor LigandsClarissa G Borba Herkenhoff, Ericka B Trarbach, Rafael Loch Batista, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|May 18, 2011
[Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil]Leonardo Vieira Neto, Julio Abucham, Luiz Antônio de Araujo, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|January 11, 2012
[Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil]Leonardo Vieira Neto, Julio Abucham, Luiz Antônio de Araujo, et al.
Neuroendocrinology|May 11, 2016
Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable EventAlessandra Casagrande, Marcello D Bronstein, Raquel S Jallad, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Growth hormone should be used only for approved indicationsDavid R Clemmons, Mark Molitch, Andrew R Hoffman, et al.
Clinical Endocrinology|August 5, 2006
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomasFelipe F Casanueva, Mark E Molitch, Janet A Schlechte, et al.
Pituitary|January 29, 2010
Management of prolactinomas in Brazil: an electronic surveyLucio Vilar, Luciana Ansaneli Naves, Luiz Augusto Casulari, et al.
The Journal of Clinical Endocrinology and Metabolism|February 10, 2015
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trialShlomo Melmed, Vera Popovic, Martin Bidlingmaier, et al.
Pituitary|June 10, 2016
Challenges in the diagnosis and management of acromegaly: a focus on comorbiditiesAlin Abreu, Alejandro Pinzón Tovar, Rafael Castellanos, et al.
Endocrine-Related Cancer|February 18, 2014
p27 variant and corticotropinoma susceptibility: a genetic and in vitro studyTomoko Sekiya, Marcello D Bronstein, Katiuscia Benfini, et al.
Pageof 10